Immu F200
Immu F200
Immu F200
Immu F200
Immu F200
Immu F200
Immu F200
Immu F200
Immu F200
Immu F200
2024

Share:

Immu F200

Automated Chemiluminescence Immunoassay

Medcaptain Medical Technology Co., Ltd.

The Immu Series Automated Chemiluminescence Immunoassay Analyzer fulfills different requirements of clinical departments and large-scale laboratories, saving procurement costs for hospitals. Analyzers can be connected to achieve higher test throughput. The analyzer supports automated calibration and control tests to free operators from manually requesting such tests, which increases testing efficiency. The analyzer has an adjustable touchscreen and ergonomic reagent tray, catering to operators of different heights. Moreover, the design of interlocking forms accentuated by elegant lines renders a reliable and user-friendly appearance.

Date of Launch
2024
Development Time
up to 24 Month
Target Regions
Africa, Asia, Europe, North America, South America
Target Groups
Trade / Industry, "doctors, nurses"

RELATED PROJECTS